Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Capecitabine in Metastatic Colorectal Cancer
NCT00459901Phase 2Terminated
- Sponsor
- Peter Kozuch
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of erlotinib in colorectal cancer (CRC), sponsored by Peter Kozuch. Primary endpoints: Time to Tumor Progression, Time to Confirmed Response and 1 more. Started Jun 2004; status: terminated.
02
Drugs
erlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00459901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459901.